
|Articles|April 1, 2004
Once-daily regimen may effectively lower IOP
Sarasota, FL-Data from three clinical trials show that Travatan/Timolol Fixed Combination (TTFC), Alcon's investigational new drug to treat glaucoma, is a safe alternative to the two single compounds dosed concomitantly, the company says.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement


















